ZARS PHARMA INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

Phase 2

Completed

Conditions: Pain
Osteoarthritis, Knee

Interventions: Drug: Transdermal Ketoprofen Patch with CHADD
Drug: Placebo transdermal patch

First Posted Date: 2005-04-19

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 118

Registration Number: NCT00108810

Locations: 🇺🇸
University Clinical Research, Pembroke Pines, Florida, United States
🇺🇸
The Center for Rheumatology and Bone Research, Washington, District of Columbia, United States
🇺🇸
Hospital for Special Surgery, New York City, New York, United States

and more 2 locations

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Phase 2

Completed

Conditions: Pain

Interventions: Drug: ZR-02-01 Fentanyl Transdermal Matrix Patch
Drug: Placebo Patch

First Posted Date: 2005-04-19

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 202

Registration Number: NCT00108771

Locations: 🇺🇸
Arizona Reserach Center, Phoenix, Arizona, United States
🇺🇸
Redpoint Research, Phoenix, Arizona, United States
🇺🇸
Sharp Rees-Stealy Medical Group, San Diego, California, United States

and more 10 locations

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults

Phase 3

Completed

Conditions: Pain

Interventions: Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

First Posted Date: 2005-04-11

Last Posted Date: 2012-06-06

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 408

Registration Number: NCT00107835

Locations: 🇺🇸
International Dermatology Research Inc., Miami, Florida, United States
🇺🇸
Laser and Skin Surgery Center of New York, New York, New York, United States
🇺🇸
Midwest Cutaneous Research, Clinton Township, Michigan, United States

and more 2 locations

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children

Phase 3

Completed

Conditions: Pain

First Posted Date: 2005-04-11

Last Posted Date: 2005-10-06

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 80

Registration Number: NCT00107822

Locations: 🇺🇸
Jacobi Medical Center, Bronx, New York, United States
🇺🇸
Tennessee Clinical Research Center, Nashville, Tennessee, United States
🇺🇸
International Dermatology Research, Inc., Miami, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy